AbbVie (WBO:ABBV) Price-to-Operating-Cash-Flow

: 13.04 (As of Today)

View and export this data going back to 2018. Start your Free Trial

As of today (2024-04-19), AbbVie's share price is €155.92. AbbVie's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €11.96. Hence, AbbVie's Price-to-Operating-Cash-Flow Ratio for today is 13.04.

The historical rank and industry rank for AbbVie's Price-to-Operating-Cash-Flow or its related term are showing as below:

WBO:ABBV' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.2 Med: 12.09 Max: 29.86
Current: 12.92

During the past 13 years, AbbVie's highest Price-to-Operating-Cash-Flow Ratio was 29.86. The lowest was 7.20. And the median was 12.09.

WBO:ABBV's Price-to-Operating-Cash-Flow is ranked better than
62.28% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.36 vs WBO:ABBV: 12.92

AbbVie's Cash Flow from Operations per share for the three months ended in Dec. 2023 was €2.45. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €11.96.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of AbbVie was -8.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 7.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 10.50% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 18.40% per year.

During the past 13 years, AbbVie's highest 3-Year average Operating Cash Flow per Share Growth Rate was 41.30% per year. The lowest was -16.90% per year. And the median was 11.20% per year.

AbbVie Price-to-Operating-Cash-Flow Historical Data

The historical data trend for AbbVie's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

9.86

10.19

10.56

11.52

12.03

AbbVie Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow																11.52	11.69	9.37	10.37	12.03

Competitive Comparison

For the Drug Manufacturers - General subindustry, AbbVie's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AbbVie Price-to-Operating-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, AbbVie's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where AbbVie's Price-to-Operating-Cash-Flow falls into.

AbbVie Price-to-Operating-Cash-Flow Calculation

AbbVie's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	155.92	/	11.959
	=	13.04

AbbVie's Share Price of today is €155.92.
AbbVie's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €11.96.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

AbbVie Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of AbbVie's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

AbbVie (WBO:ABBV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (WBO:ABBV) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

ABBV:USA ABBV:Mexico 1ABBV:Italy 4ABd:UK 0QCV:UK 4AB:Germany ABBV:Canada ABBV34:Brazil

Address

1 North Waukegan Road, North Chicago, IL, USA, 60064-6400

Website

http://www.abbvieinvestor.com

AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.